Canada Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada Rowan DunneSeptember 2, 2022
International Short Wave and Sheba partner for clinical trial aimed at combatting anorexia Innovative new studies in the Middle East receive approval from Israeli Ministry of Health Rowan DunneAugust 15, 2022
Psychedelics Sage Institute receives grant to help continue its psychedelic therapy in California Cohen Foundation proudly supports organization dedicated to aiding underserved communities Rowan DunneJuly 27, 2022
Psychedelics Field Trip administers new synthetic molecule in Australia Initial dose of FT-104 given in Adelaide, company announces name change Rowan DunneJuly 22, 2022
News More Canadians, Americans open to psychedelic therapy, surveys show Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues Jared GnamMay 20, 2021
Canada Numinus to test natural psilocybin safety in Phase 1 trial Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy Jared GnamApril 27, 2021
Medical and Pharmaceutical Psilocybin treats depression as well as common antidepressant: study The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine Jared GnamApril 15, 2021
Psychedelics 2020’s top 5 advancements in psychedelics With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field Jared GnamDecember 30, 2020
Health and Safety What Measure 109 means for the future of psychedelic therapy After a successful ballot measure, a broad set of onlookers focuses on Oregon to gauge the social and economic impacts of licensed psilocybin therapy Amna ShamimDecember 15, 2020
Industry update Mydecine to make first legal import of psilocybin mushrooms into Canada Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments Jared GnamDecember 11, 2020